Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine infusion during breast cancer surgery feasibility trial
ACTRN12618000463279Phase 3Active, not recruiting
- Sponsor
- Royal Perth Hospital
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in breast cancer and Persistent postsurgical pain (PPSP) comparing Lidocaine infusion with Placebo infusion (2 arms). Primary endpoints: Trial feasibility, Lidocaine plasma concentration adequacy and 1 more. Started Oct 2018; status: active, not recruiting.
02
Drugs
lidocaine
03
Conditions
breast cancerPersistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on ACTRN12618000463279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000463279.